Gut-hormone profile in coeliac disease

Area of Science:

• Gastroenterology
• Endocrinology
• Immunology

Background:

• Coeliac disease is an autoimmune disorder triggered by gluten ingestion.
• It primarily affects the small intestine, causing inflammation and malabsorption.
• Altered gastrointestinal hormone release is a known consequence of small intestinal mucosal damage.

Purpose of the Study:

• To investigate the specific patterns of gut hormone release in patients with coeliac disease.
• To determine if the gut hormone profile correlates with the location of mucosal lesions.
• To explore the potential utility of gut hormone profiles in characterizing gastrointestinal diseases.

Main Methods:

• Patient blood samples were collected to measure hormone levels.
• Hormone release was assessed from different segments of the small intestine.
• Levels of secretin, gastric inhibitory polypeptide, enteroglucagon, neurotensin, gastrin, and pancreatic polypeptide were quantified.

Main Results:

• A significant reduction in secretin and gastric inhibitory polypeptide release from the upper small intestine was observed.
• A marked increase in enteroglucagon and neurotensin release from the lower small intestine was found.
• Gastrin and pancreatic polypeptide release remained normal, indicating localized effects.

Conclusions:

• The gut hormone profile in coeliac disease patients directly reflects the location of the small intestinal mucosal lesion.
• Altered gut hormone release patterns may serve as a biomarker for coeliac disease.
• The gut-hormone profile shows potential for characterizing other gastrointestinal disorders.